ID: ALA5092567

Max Phase: Preclinical

Molecular Formula: C23H14F9N3O6S2

Molecular Weight: 663.50

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)/C=C1\S/C(=N\N=C\c2ccc(OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc2)N(c2ccccc2)C1=O

Standard InChI:  InChI=1S/C23H14F9N3O6S2/c1-40-17(36)11-16-18(37)35(14-5-3-2-4-6-14)19(42-16)34-33-12-13-7-9-15(10-8-13)41-43(38,39)23(31,32)21(26,27)20(24,25)22(28,29)30/h2-12H,1H3/b16-11-,33-12+,34-19-

Standard InChI Key:  LDQHCKDKEYTNLT-IJYVDFDLSA-N

Associated Targets(Human)

UACC-62 47335 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 663.50Molecular Weight (Monoisotopic): 663.0180AlogP: 5.35#Rotatable Bonds: 9
Polar Surface Area: 114.70Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.38CX LogD: 6.38
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.09Np Likeness Score: -0.95

References

1. Tantawy AH, El-Behairy MF, Abd-Allah WH, Jiang H, Wang MQ, Marzouk AA..  (2021)  Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Fluorinated Candidates as PI3K Inhibitors: Targeting Fluorophilic Binding Sites.,  64  (23.0): [PMID:34791873] [10.1021/acs.jmedchem.1c01674]

Source